Buy
₹1,088
₹1,038.5
₹1,500
37.87%
Motilal Oswal Financial Services Limited (MOFSL), in its July 25, 2026 results update, retained its Buy recommendation on Tata Consumer Products. The view is supported by earnings growth in the Indian branded business, momentum in the growth portfolio and expectations of sustained margin expansion.
The broker believes Tata Consumer Products can maintain double-digit growth through approximately 25-30% growth in the growth portfolio, mid-single-digit volume growth in Indian tea, 5-7% growth in salt and healthier US international-business performance as coffee prices normalise.
Tata Consumer Products reported consolidated revenue of Rs 5,350 crore in 1QFY27, up 12% year on year and in line with MOFSL estimates. EBITDA increased 19% year on year to Rs 720 crore, also in line with estimates. EBITDA margin expanded 80 basis points year on year to 13.5%, supported by a 260-basis-point improvement in gross margin to 42.7% from 40.1% in 1QFY26. Adjusted EPS rose to Rs 4.67 from Rs 3.73 a year earlier.
Overall EBIT increased approximately 27% year on year, led by 36% growth in Indian branded-business EBIT and approximately 13% growth in international-business EBIT.
| 1QFY27 metric | Reported performance | Year-on-year change |
|---|---|---|
| Consolidated revenue | Rs 5,350 crore | 12% growth |
| EBITDA | Rs 720 crore | 19% growth |
| EBITDA margin | 13.5% | 80 basis points expansion |
| Gross margin | 42.7% | 260 basis points higher |
| Adjusted EPS | Rs 4.67 | Up from Rs 3.73 |
The Indian branded business delivered revenue of Rs 3,540 crore, up 13% year on year, while EBIT increased 36% to Rs 390 crore.
NourishCo ready-to-drink revenue rose approximately 41% to Rs 380 crore, supported by 35% volume growth. Growth businesses, comprising RTD, Capital Foods and Organic India, grew 47%, while Tata Sampann increased 58%. Sampann's core portfolio grew 30%, with traction in dry fruits, cold-pressed oils, pulses and spices. Organic India and Capital Foods together grew 35%. Management has guided for approximately 25-30% growth in the growth business over the coming quarters.
Management stated that Indian tea volumes increased approximately 2% despite LPG-related disruption and an unusually intense summer. Tea input costs were approximately 7-10% higher. Tata Consumer Products took a price increase in June and intends to implement calibrated pass-throughs to protect margins while balancing affordability and volume growth.
International branded-beverages revenue grew 17% to approximately Rs 1,340 crore, while EBIT increased 13% to Rs 180 crore. The international business grew 16%, or 3% in constant-currency terms. The US grew 7% in constant currency and margins expanded as coffee prices normalised. In contrast, UK revenue declined 2% in constant currency because of weak everyday black-tea demand during an intense summer.
Non-branded revenue declined 7% to approximately Rs 490 crore, while EBIT fell 24% to Rs 49 crore, principally because of lower global coffee prices. Soluble revenue declined 12% and plantations revenue declined 8%.
| Business area | 1QFY27 performance |
|---|---|
| Indian branded business | Revenue of Rs 3,540 crore, up 13%; EBIT of Rs 390 crore, up 36% |
| NourishCo RTD | Revenue of Rs 380 crore, up approximately 41%; volume growth of 35% |
| Growth businesses | Growth of 47%; Tata Sampann up 58% |
| International branded beverages | Revenue of approximately Rs 1,340 crore, up 17%; EBIT of Rs 180 crore, up 13% |
| Non-branded business | Revenue of approximately Rs 490 crore, down 7%; EBIT of Rs 49 crore, down 24% |
Management launched 14 products in 1QFY27 and indicated a robust pipeline for the rest of FY27. RTD added two Kombucha Zero variants. Starbucks revenue grew approximately 11%, with margin expansion from operating leverage. Four cafés were added, and management guided for high single-digit business growth.
Advertising and promotion spending in India was 6.1% of sales. MOFSL expects margin expansion from premiumisation, innovation, better go-to-market execution, e-commerce penetration and a rising contribution from higher-margin growth and health-and-wellness categories.
MOFSL largely maintained its FY27E and FY28E estimates, raising adjusted PAT by 2% for each year while leaving revenue and EBITDA estimates broadly unchanged. It forecasts FY26-28 revenue, EBITDA and PAT CAGRs of 10%, 16% and 21%, respectively.
MOFSL's sum-of-the-parts target price is Rs 1,500. The valuation assigns 38 times FY28E EV/EBITDA to the India branded business, 13 times to the international branded business, 13 times to the non-branded business and values Starbucks through a DCF.
Disclaimer: This is a summary of a research report published by the broker/research house identified above. The views, recommendations, target prices and estimates are those of the respective broker and do not represent DSIJ investment advice. The summary may be AI-assisted, hence please refer to the original report for complete details, disclosures and risks.
Copyright 2026 by DSIJ Wealth Advisory Pvt. Ltd. (Formerly Known as DSIJ Pvt. Ltd.)